HUM
NYSE · Health Care
Humana Inc
$360.72
+0.07 (+0.02%)
HUM News30 articles
AI-Driven Healthcare Fraud Surge Strains Insurers, Coverage Gaps Widen
AI is fueling healthcare fraud with fake medical records and bot calls, driving up costs and exposing coverage gaps as insurers scramble to adapt.
Alignment Healthcare Surges 25% on Raised 2026 Guidance, Strong Q1
Alignment Healthcare stock surged 25% after raising its 2026 guidance and reporting strong Q1 earnings, driven by disciplined growth and stable utilization trends.
UnitedHealth Rises as Analysts See Easing Medical Costs
UnitedHealth shares climbed 5.7% after Bank of America upgraded the stock to Buy and Morgan Stanley raised its price target, citing easing medical costs and a favorable Q2 setup.
UnitedHealth Drops Premarket After Berkshire Exits Stake
UnitedHealth shares dropped 4.8% in premarket trading after Berkshire Hathaway disclosed it sold its stake in the insurer, dampening sentiment despite strong Q1 results.
Berkshire Exits UnitedHealth; Optum AI Monitoring Revealed
Berkshire Hathaway exited its UnitedHealth stake in Q1, reversing a position that had boosted sentiment. UnitedHealth also monitors Optum staff AI tool usage as it expands technology.
Stocks Dip as Oil Surge Fuels Inflation Fears, Fed Cut Hopes Fade
US stocks retreated Tuesday as a hotter-than-expected April CPI report and surging oil prices dampened rate-cut expectations, with tech and chip stocks leading declines.
UnitedHealth Shares Surge as Investors Bet on Recovery, PBM Reform
UnitedHealth shares climbed 3.1% as the company unveiled a new Optum Rx fee-based pricing model and raised 2026 profit guidance, signaling a potential turnaround.
Humana Shares Surge 11% on Medicare Advantage Optimism
Humana shares surged 11.27% on Friday amid renewed Medicare Advantage optimism after CVS raised its 2026 profit outlook, though concerns over Star Ratings and funding persist.
UnitedHealth Stock Rebounds on Easing Medical Costs and Raised Outlook
UnitedHealth shares rose 2.8% to $379.98, extending gains on easing medical-cost pressures. Q1 revenue hit $111.7B, and the company raised its full-year adjusted earnings outlook above $18.25/share.
Humana Stock Rally Tests Valuation as Profit Forecast Slips
Humana lowered its 2026 GAAP EPS forecast to at least $8.36, while its stock has surged over 25% in a month, pushing the P/E ratio above 26.
Blue Cross Blue Shield $2.67B Settlement Payouts Begin in May 2026
Blue Cross Blue Shield settlement payments start in May 2026 for eligible claimants in a $2.67 billion antitrust case. Payouts vary based on claims and premiums, with an estimated average of $333.
UnitedHealth Eases Prior Authorization Rules; UNH Shares Gain
UnitedHealth Group shares climbed 1% after the company announced it will eliminate prior authorization for 30% of services by 2026, including outpatient surgeries and diagnostic tests.
Humana Shares Slide Despite Q1 Earnings Beat as Medicare Advantage Challenges Persist
Humana beat Q1 profit estimates but shares fell over 6% premarket as it kept its 2026 outlook unchanged and cut GAAP guidance, citing Medicare Star Ratings headwinds.
Blue Cross Blue Shield Settlement Payouts to Begin in May
Payments from the $2.67 billion Blue Cross Blue Shield antitrust settlement begin in May 2026 for eligible claimants who filed by November 2021.
UnitedHealth, Health Insurers Rally on Centene Profit Outlook Boost
UnitedHealth Group shares rose about 4% Tuesday after Centene lifted its profit outlook, fueling hopes that medical-cost pressures are easing for major insurers.
Futures Gain on Iran Ceasefire Extension; Tesla, Airlines in Focus
U.S. stock futures advanced Wednesday morning following an extension of the Iran ceasefire. Investors are monitoring oil prices and a busy earnings calendar featuring Tesla and United Airlines.
Stocks Retreat as Oil Surge, Fed Jitters Undercut Rally
Major U.S. equity indices turned lower Tuesday afternoon, surrendering morning advances as climbing crude prices and bond yields introduced fresh uncertainty. The S&P 500 declined 0.32% to 7,086.48.
UnitedHealth Shares Rally on Medicare Advantage Rate Decision Ahead of Q1 Report
UnitedHealth Group shares advanced following a finalized 2.48% increase to 2027 Medicare Advantage payment rates, which exceeds initial projections. The company is set to report first-quarter results on April 21 amid expectations for an earnings decline.
UnitedHealth Shares Drop Ahead of Q1 Report, Sector Under Pressure
UnitedHealth Group shares declined sharply Friday, extending weekly losses as the market anticipates first-quarter results. The health insurance sector broadly retreated.
UnitedHealth Files Shelf Registration, Names New Accounting Chief
UnitedHealth Group shares gained 0.5% in after-hours trading after filing a shelf registration for future securities offerings and appointing a new chief accounting officer. The company's annual report revealed Optum Rx's $188 billion drug spend and a projected Medicare Advantage membership decline for 2026.
UnitedHealth Files Shelf Registration, Announces Accounting Leadership Change
UnitedHealth Group shares gained 0.5% in after-hours trading to $294.93 after filing a shelf registration for future securities offerings and appointing Dennis Stankiewicz as chief accounting officer.
UnitedHealth Implements Pay Freeze, Dividend Amid Cost Pressures
UnitedHealth Group has limited employee pay increases to a range of 0% to 2% and initiated layoffs, a move aligning with broader cost-control efforts. The company's board also approved a quarterly cash dividend of $2.21 per share.
Wesfarmers Shares Slide Despite Profit Beat as Consumer Spending Concerns Mount
Wesfarmers shares tumbled over 5% despite reporting a half-year profit beat, as management flagged patchy consumer spending and upcoming price investments, overshadowing solid financial results.
UnitedHealth Rallies Ahead of Key Medicare Decision
UnitedHealth Group shares closed 3.1% higher at $293.19 on Friday, marking a three-day rally. Investors are now focused on the upcoming final 2027 Medicare Advantage rate decision.
Healthcare ETF Rises on Dexcom, Moderna Earnings; Markets Eye Holiday
Healthcare stocks advanced Friday, with the XLV ETF rising 1.1% as Dexcom and Moderna posted strong quarterly results. U.S. markets are closed Monday for the Presidents Day holiday.
UnitedHealth Gains Amid Market Rout as Medicare Advantage Deadlines Loom
UnitedHealth shares advanced nearly 2% on Thursday, defying a broad market decline, as attention turned to key Medicare Advantage policy deadlines and a profit warning from peer Humana.
Humana Shares Decline on Reduced 2026 Profit Outlook Due to Medicare Star Ratings
Humana's stock fell nearly 2% after the health insurer projected 2026 adjusted earnings of at least $9 per share, significantly below analyst estimates, citing a $3.5 billion impact from lower Medicare Advantage star ratings.
UnitedHealth Gains Amid Medicare Rate Uncertainty and ACA Investigations
UnitedHealth shares edged higher as investors monitored upcoming Medicare Advantage payment decisions and a House Republican probe into ACA insurers. The sector traded mixed.
UnitedHealth Dips After Hours as Medicare Rate Decision Looms
UnitedHealth shares edged lower in extended trading Monday as healthcare stocks underperformed the broader market. Investors are focused on upcoming Medicare Advantage reimbursement updates, with the final rates expected in early April.
UnitedHealth Rallies 3% to Close Volatile Week; Medicare Advantage Outlook in Focus
UnitedHealth shares gained 3% Friday to $276.65, stabilizing after a turbulent period for managed-care stocks. Investors now await earnings from CVS Health and Humana next week for critical updates on Medicare Advantage trends.